US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

The Oncology Institute

6.53

+0.16002.51%

Post-market: 6.540.0100+0.15%17:45 EDT

Volume:1.39M

Turnover:9.06M

Market Cap:665.51M

PE:-21.46

High:6.69

Open:6.42

Low:6.38

Close:6.37

52wk High:7.05

52wk Low:2.32

Shares:101.92M

Float Shares:88.60M

Volume Ratio:1.39

T/O Rate:1.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3042

EPS(LYR):-0.5445

ROE:--

ROA:-9.65%

PB:-26.71

PE(LYR):-11.99

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Starling Oncology Forecasts Fy2026 Revenue of $650-670 Million

Starling Oncology - Brad Hively no Longer Serves as Vice Chairman or Committee Member Effective Immediately - SEC Filing

THOMSON REUTERS

Starling Oncology - Brad Hively Will not Stand for Re-Election to Starling Oncology Board at 2027 Annual Meeting - SEC Filing

THOMSON REUTERS

Starling Oncology Director Brad Hively to Step Down as Vice Chairman, not Seek Re-Election in 2027

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/STLN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"STLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STLN\",,,,,undefined,":{"symbol":"STLN","market":"US","secType":"STK","nameCN":"The Oncology Institute","latestPrice":6.53,"timestamp":1789588800000,"preClose":6.37,"halted":0,"volume":1388405,"hourTrading":{"tag":"盘后","latestPrice":6.54,"preClose":6.53,"latestTime":"17:45 EDT","volume":34433,"amount":224853.70515650001,"timestamp":1789595157853,"change":0.01,"changeRate":0.001531,"amplitude":0.001531},"delay":0,"changeRate":0.02511773940345371,"floatShares":88601299,"shares":101916100,"eps":-0.304237,"marketStatus":"Post-Mkt","change":0.16,"latestTime":"09-16 18:48:36 EDT","open":6.42,"high":6.69,"low":6.375,"amount":9055633.362202,"amplitude":0.049451,"askPrice":6.54,"askSize":6,"bidPrice":6.53,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-0.304237,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":6.37,"preHourTrading":{"tag":"盘前","latestPrice":6.15,"preClose":6.37,"latestTime":"08:55 EDT","volume":267,"amount":1712.5829628000001,"timestamp":1789563357611,"change":-0.22,"changeRate":-0.034537,"amplitude":0.047096},"postHourTrading":{"tag":"盘后","latestPrice":6.54,"preClose":6.53,"latestTime":"17:45 EDT","volume":34433,"amount":224853.70515650001,"timestamp":1789595157853,"change":0.01,"changeRate":0.001531,"amplitude":0.001531},"volumeRatio":1.389635,"impliedVol":1.1867,"impliedVolPercentile":0.871},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STLN\",,,,,undefined,":{"symbol":"STLN","floatShares":88601299,"roa":"-9.65%","roe":"--","lyrEps":-0.544488,"volumeRatio":1.389635,"shares":101916100,"dividePrice":0,"high":6.69,"amplitude":0.049451,"preClose":6.37,"low":6.375,"week52Low":2.32,"pbRate":"-26.71","psRate":"1.13","week52High":7.05,"institutionHeld":0,"latestPrice":6.53,"committee":0.333333,"eps":-0.304237,"divideRate":0,"volume":1388405,"delay":0,"ttmEps":-0.304237,"open":6.42,"prevYearClose":3.56,"prevWeekClose":6.17,"prevMonthClose":5.91,"prevQuarterClose":5.43,"fiveDayClose":6.29,"twentyDayClose":6.4,"sixtyDayClose":5.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/STLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"STLN","fiscalQuarterEnding":"2026/06","expectedEps":-0.07,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.08},{"date":"2026-05-06","symbol":"STLN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778097600000,"name":null,"time":"Post-Mkt","dateTimestamp":1778040000000,"actualEps":null},{"market":"US","date":"2026-03-12","symbol":"STLN","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-11-13","symbol":"STLN","fiscalQuarterEnding":"2025/09","expectedEps":-0.12,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-08-13","symbol":"STLN","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"STLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"STLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1783396800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/STLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"STLN","date":"2026-09-15","current":-21.134839,"percent":0.103448,"low":-18.702266,"twenty":-18.022694,"median":-17.494762,"eighty":-16.674783,"high":-11.557791,"avg":-16.89093,"sd":1.922712,"marketCap":664493069},"quantilePoints":[{"date":"2026-08-07","current":-13.746861,"twenty":-12.626432,"median":-11.833524,"eighty":-11.695657,"marketCap":498914835},{"date":"2026-08-14","current":-17.579006,"twenty":-17.646402,"median":-17.298192,"eighty":-11.842715,"marketCap":637994879},{"date":"2026-08-21","current":-18.365288,"twenty":-18.045159,"median":-17.64921,"eighty":-12.999908,"marketCap":666531392},{"date":"2026-08-28","current":-17.803658,"twenty":-18.129404,"median":-17.719414,"eighty":-15.827113,"marketCap":646148169},{"date":"2026-09-04","current":-16.764643,"twenty":-18.045159,"median":-17.487741,"eighty":-16.646701,"marketCap":608439206},{"date":"2026-09-11","current":-17.410518,"twenty":-17.988996,"median":-17.494762,"eighty":-16.66355,"marketCap":631879913},{"date":"2026-09-15","current":-18.309125,"twenty":-18.022694,"median":-17.494762,"eighty":-16.674783,"marketCap":664493069}],"updateTime":1789579444842},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"STLN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666582310","title":"Starling Oncology Forecasts Fy2026 Revenue of $650-670 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582310","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582310?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:38","pubTimestamp":1788950292,"startTime":"0","endTime":"0","summary":"Starling Oncology forecasts FY2026 revenue of $650-670 millionStarling Oncology forecast FY26 revenue of USD 650-670 million, based on guidance reiterated in its Aug. 6, 2026 2Q26 release.Adjusted EBI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL1fb2rf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818219","title":"Starling Oncology - Brad Hively no Longer Serves as Vice Chairman or Committee Member Effective Immediately - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818219","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818219?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:06","pubTimestamp":1788343574,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664182148","title":"Starling Oncology - Brad Hively Will not Stand for Re-Election to Starling Oncology Board at 2027 Annual Meeting - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664182148","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664182148?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:06","pubTimestamp":1788343574,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818291","title":"Starling Oncology Director Brad Hively to Step Down as Vice Chairman, not Seek Re-Election in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818291","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818291?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:05","pubTimestamp":1788343526,"startTime":"0","endTime":"0","summary":"Starling Oncology director Brad Hively to step down as vice chairman, not seek re-election in 2027Starling Oncology director Brad Hively will not stand for re-election at the 2027 annual stockholders ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL98mpdb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/STLN\",params:#limit:6,delay:false,,,undefined,":[]}}